EUVIMEDEUVIMED entdecken
Crossref

Protective effects of KML29 in intestinal ischemia-reperfusion injury: An experimental study

İbrahim Çaltekin, Ali Aygün, Adem Köksal, Emin Kaymak, Adem Tokpınar, Mahmud Mustafa Ozkut

Turkish Journal of Trauma and Emergency Surgery · 2025

DOI: 10.14744/tjtes.2025.72686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Trauma and Emergency Surgery, 2025. Verfasst von İbrahim Çaltekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Ordu University Faculty of Medicine, Ordu-Türkiye. Hauptthemen laut MEDLINE: Reperfusion Injury, Mesenteric Ischemia, Intestines, Thiocarbamates.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute mesenteric ischemia (AMI) is a potentially fatal vascular emergency that results in tissue damage due to ischemia-reperfusion injury (IRI) and is difficult to diagnose and treat in its early stages. Monoacylglycerol lipase inhibitors have demonstrated protective effects against ischemia-reperfusion injury due to their antioxidant and anti-inflammatory properties. This study aimed to evaluate the effects of KML29, a potent and selective monoacylglycerol lipase inhibitor, on intestinal IRI. METHODS: Thirty-two female Wistar albino rats were divided into four groups: Group 1 - Sham; Group 2 - Ischemia/Reperfusion (IR); Group 3 - IR + KML29 (2 mg/kg); and Group 4 - IR + KML29 (10 mg/kg). Intestinal ischemia-reperfusion was induced by occluding the superior mesenteric artery for 45 minutes, followed by 60 minutes of reperfusion. KML29 was administered intraperitoneally to Groups 3 and 4 at doses of 2 mg/kg and 10 mg/kg, respectively, 30 minutes prior to surgery. Intestinal IRI was evaluated using histopathological and biochemical parameters. RESULTS: Treatment with 10 mg/kg KML29 was associated with improved histopathological findings in the IR group (p=0.0001). Elevated levels of nuclear factor kappa B (NF-kB), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and transforming growth factor-beta 1 (TGF-β1) observed in the IR group were significantly reduced following administration of 10 mg/kg KML29 (p=0.0001). Additionally, treatment with both 2 mg/kg and 10 mg/kg doses of KML29 significantly reduced the number of apoptotic cells in the IR group (p=0.0001). CONCLUSION: In conclusion, this study demonstrated that treatment with both doses of KML29 (2.5 mg/kg and 10 mg/kg) significantly reduced the number of apoptotic cells and inflammatory markers, and improved histopathological findings in the intestinal tissues of rats subjected to IR. With its anti-inflammatory and anti-apoptotic properties, KML29 may represent a novel therapeutic option for the treatment of mesenteric ischemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryMesenteric IschemiaIntestinesThiocarbamatesAnimalsRats, WistarFemaleRatsDisease Models, Animal

Substanzen

Thiocarbamates

Autor:innen und Institutionen

  • Department of Emergency Medicine, Ordu University Faculty of Medicine, Ordu-Türkiye.
  • Department of Histology and Embryology, Yozgat Bozok University Faculty of Medicine, Yozgat-Türkiye.
  • Department of Anatomy, Ordu University Faculty of Medicine, Ordu-Türkiye.
  • Department of Histology and Embryology, Afyonkarahisar Health Sciences University Faculty of Medicine, Afyonkarahisar-Türkiye.

Zitieren

APA

Çaltekin, İ., Aygün, A., Köksal, A., Kaymak, E., Tokpınar, A., & Ozkut, M. M. (2025). Protective effects of KML29 in intestinal ischemia-reperfusion injury: An experimental study. Turkish Journal of Trauma and Emergency Surgery. https://doi.org/10.14744/tjtes.2025.72686

Vancouver

Çaltekin İ, Aygün A, Köksal A, Kaymak E, Tokpınar A, Ozkut MM. Protective effects of KML29 in intestinal ischemia-reperfusion injury: An experimental study. Turkish Journal of Trauma and Emergency Surgery. 2025. doi:10.14744/tjtes.2025.72686

BibTeX
@article{altekin2025,
  author = {Çaltekin, İbrahim and Aygün, Ali and Köksal, Adem and Kaymak, Emin and Tokpınar, Adem and Ozkut, Mahmud Mustafa},
  title = {Protective effects of KML29 in intestinal ischemia-reperfusion injury: An experimental study},
  journal = {Turkish Journal of Trauma and Emergency Surgery},
  year = {2025},
  doi = {10.14744/tjtes.2025.72686}
}
Kostenlos starten →